Drug Report History #122033
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v12-FR | Version v1-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2020-10-13 (Updated) | 2020-08-11 |
| Drug Identification Number | 02353903 | 02353903 |
| Brand name | FEIBA NF | FEIBA NF |
| Common or Proper name | anti-inhibitor coagulant complex | anti-inhibitor coagulant complex |
| Company Name | SHIRE PHARMA CANADA ULC | SHIRE PHARMA CANADA ULC |
| Ingredients | ANTI-INHIBITOR COAGULANT COMPLEX | ANTI-INHIBITOR COAGULANT COMPLEX |
| Strength(s) | 3250UNIT | 3250UNIT |
| Dosage form(s) | POWDER FOR SOLUTION KIT | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | Labelled 2500 U (Updated) | 2500 IU |
| ATC code | B02BD | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2020-08-11 | 2020-08-11 |
| Actual start date | 2020-08-11 | 2020-08-11 |
| Estimated end date | 2020-09-30 | 2020-09-30 |
| Actual end date | 2020-10-01 (Updated) | |
| Shortage status | Resolved (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Feiba 1000 U is currently available. (Updated) | Feiba 1000 IU is currently available. |
| Health Canada comments |